Join the conversation (or start a discussion) on the BioQC user community
Become a BioQC Insider!
Beyond GMP: Selecting and Managing CDMOs for Biological Products
30 September 2026 | Articulate why regulatory compliance is an entry criterion, not a differentiator, and identify the three failure modes that standard audits consistently miss for biological products.
The Use of Capillary Electrophoresis in Cell and Gene Therapy and Vaccine Development
4 November 2026 | Addressing emerging analytical challenges, evolving regulatory expectations, and potential solutions for developing robust, fit-for-purpose CE methods for next-generation CGT and vaccine products.
Recent Advances in Process Analytical Technology (PAT) for Downstream and Upstream Processing
9 December 2026 | PAT implementation, effects on yield, consistency, and scalability, and the roles of modelling and chemometrics in facilitating advanced monitoring and control strategies
Breaking through analytical boundaries: Development of next-generation gene therapies and vaccines
PDF download | Benefit from expert Q&A and tips & tricks in this Cell and Gene Therapy (CGT) Compendium
Advertisement
Advertisement
Advertisement